Randomized Controlled Trial Comparing a Conservative Management and Laser Surgery
NCT01220011
Anemia, Anemia, Neonatal
Aurora, Colorado, United States
View Trial DetailsNCT Number: NCT01178177
Invasive pulmonary aspergillosis (IPA) is an opportunistic infection that primarily affects recipients of solid organ transplants (SOTs) and patients with chemotherapy- induced neutropenia.Although both of these populations are at high risk for IPA, they differ with regards to the specific defects in host defense mechanisms that increase their risk for IPA. Chemotherapy- induced neutropenia is the principal defect affecting patients with hematologic malignancies, whereas transplant recipients tend to have dysfunctional T cells and phagocytes, as a result of immunosuppressive drug therapy. Thus, the patterns of IPA-related infection and inflammation may differ according to the type of underlying immune defect. Although the clinical and radiological features of IPA in patients with neutropenia have been extensively studied, little is known about the characteristics of IPA in SOT recipients. The investigators therefore compared the IPA- related clinical and radiological findings in SOT recipients with those of neutropenic patients.
Looking for future studies?
Notify Me16 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Asan Medical Center
Other
Retrospective Analysis of Radiologic Features of Invasive Pulmonary Aspergillosis in Transplant Recipients and Neutropenic Patients.Transplant Recipients and Neutropenic Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01220011
Anemia, Anemia, Neonatal
Aurora, Colorado, United States
View Trial DetailsNCT00001715
Hematologic Disease, Hematologic Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT03013439
Anemia, Anemia, Hypochromic
Tokyo, Japan
View Trial DetailsNCT01426295
Hematologic Disease, Hematologic Diseases
Nantes, France
View Trial Details